Measuring or testing processes involving enzymes, nucleic acids or microorganisms ; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
An Isothermal Diagnostic Test that Utilizes a Cas Protein and a Polymerase
#2COMPOSITIONS AND METHODS FOR IN SITU SINGLE CELL ANALYSIS USING ENZYMATIC NUCLEIC ACID EXTENSION
#3METHODS OF SEQUENCING USING 3' ALLYL BLOCKED NUCLEOTIDES
#4METHOD AND KIT FOR DETECTING EDITING SITES OF BASE EDITOR
#5OLIGO-MODIFIED NUCLEOTIDE ANALOGUES FOR NUCLEIC ACID PREPARATION
#6ISOTHERMAL GENE AMPLIFICATION METHOD, GENE DETECTION METHOD, VIRUS DETECTION METHOD, AND KIT USED THEREFOR
#7CYANINE DERIVATIVES AND RELATED USES
#8METHOD FOR TESTING PRESENCE OR LEVEL OF ONE OR MORE TARGET NUCLEIC ACIDS IN SAMPLE
#9METHOD FOR TESTING AND SCREENING P38 MAP KINASE MODIFIERS
#10SFLT1 MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#11METHOD FOR MEDIUM-THROUGHPUT MULTI-SINGLE-CELL REPRESENTATIVE DNA METHYLATION LIBRARY CONSTRUCTION AND SEQUENCING
#12NANOPORE TWEEZER APPROACH FOR PROTEIN KINASE ALLOSTERIC DRUG SCREENING
#13METHODS OF SEQUENCING USING 3' BLOCKED NUCLEOTIDES
#14METHODS FOR TETHERING RIBONUCLEIC ACIDS IN BIOLOGICAL SAMPLES
#15SINGLE-BUFFER COMPOSITIONS FOR NUCLEIC ACID DETECTION
#16Method for Constructing RNA Sequencing Library, Sequencing Method and Kit
#17CHIMERIC DNA POLYMERASE AND APPLICATION THEREOF
#18POLYMER
#19BLOCKING OLIGONUCLEOTIDES FOR THE SELECTIVE DEPLETION OF NON-DESIRABLE FRAGMENTS FROM AMPLIFIED LIBRARIES
#20KINASE MUTANTS AND USES THEREOF
#21HIGH-RESOLUTION SPATIAL TRANSCRIPTOME
#22METHODS FOR BIOMOLECULE ANALYSIS EMPLOYING MULTI-COMPONENT DETECTION AGENT AND RELATED KITS
#23SYSTEM AND METHODS OF DETECTION OF ONCRNAS FOR CANCER DIAGNOSIS
#24METHODS OF TREATING CANCER USING DKK-1 INHIBITORS
#25METHOD FOR MEDIUM-THROUGHPUT MULTI-SINGLE-CELL REPRESENTATIVE DNA METHYLATION LIBRARY CONSTRUCTION AND SEQUENCING
#26NANOPORE TWEEZER APPROACH FOR PROTEIN KINASE ALLOSTERIC DRUG SCREENING
#27COMPOUNDS AND METHODS OF IDENTIFYING, SYNTHESIZING, OPTIMIZING AND PROFILING PROTEIN MODULATORS
#28THERMOPHILIC COMPOSITIONS FOR NUCLEIC ACID AMPLIFICATION
#29Treatment of a Senescence-Associated Ocular Disease or Disorder Using a Bcl-xL Selective Inhibitor
#30PREVENTION AND/OR TREATMENT OF INFLAMMATORY SKIN DISEASE
#31FRET Biosensor for Detecting and Reporting NAD+/NADH Ratio Changes
#32BIOMARKER ASSAY FOR USE IN MONITORING AUTISM
#33COMPOSITIONS, SYSTEMS AND METHODS FOR CRISPR-BASED ENZYME OPTIMIZATION
#34CHEMICAL INHIBITORS AGAINST KINASES TO BLOCK TELOMERE ELONGATION IN CANCER
#35RNA AND DNA ANALYSIS USING ENGINEERED SURFACES
#36TARGETED SEQUENCE ADDITION
#37COMPOSITIONS AND METHODS INVOLVING ENGINEERED P27
#38Methods for identifying a location of an RNA in a biological sample
#39SIMULTANEOUS AMPLIFICATION OF DNA AND RNA FROM SINGLE CELLS
#40[18F]-LABELED IMIDAZOPYRIDINE DERIVATIVES AS PET RADIOTRACER
#41BIOSENSORS FOR DETECTING AND/OR NEUTRALIZING BIOAVAILABLE URANIUM AND RELATED U-SENSITIVE GENETIC MOLECULAR COMPONENTS, GENE CASSETTES, VECTORS, GENETIC CIRCUITS, COMPOSITIONS, METHODS AND SYSTEMS
#42MULTIPLEXED PROTEOMICS AND PHOSPHOPROTEOMICS
#43METHODS FOR PREDICTING THE RESPONSE OF A PATIENT TO TREATMENT WITH A PD-1 OR PD-L1 IMMUNE CHECKPOINT INHIBITOR
#44IMMOBILIZED PROTEIN SYSTEM FOR RAPID AND ENHANCED MULTIPLEXED DIAGNOSTICS
#45MAP4K3 SMALL MOLECULE DRUG INHIBITORS AND METHODS OF USE THEREOF
#46LZHEIMER'S DISEASE-SPECIFIC ALTERATIONS OF PROTEIN KINASE C EPSILON (PKC-EPSILON PROTEIN LEVELS
#47DIAGNOSIS METHODS, DIAGNOSTIC AGENTS, AND THERAPEUTIC AGENTS AGAINST ALZHEIMER'S DISEASE AND FRONTOTEMPORAL LOBAR DEGENERATION, AND SCREENING METHODS FOR THESE AGENTS
#48Amino acid-sensing diguanylate cyclase and methods of use
#49CRYSTAL STRUCTURE OF BTK PROTEIN AND BINDING POCKETS THEREOF
#50SELF-IMMOLATIVE PROBES FOR ENZYME ACTIVITY DETECTION
#51PROLINE HYDROXYLATION PRIMES PROTEIN KINASES FOR AUTOPHOSPHORYLATION AND ACTIVATION
#52SCREENING METHOD FOR TELOMERASE REVERSE TRANSCRIPTASE (TERT) PHOSPHORYLATION INHIBITORS
#53Lymphocyte-Based PKCe Test for Alzheimer's Disease
#54VECTOR SET FOR MEASURING TRANSPOSASE ACTIVITY, KIT, TRANSPOSASE ACTIVITY MEASURING METHOD, AND CELL SEPARATION METHOD
#55Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent
#56FLUORESCENT PROTEIN BIOSENSOR FOR DETECTION OF KINASE ACTIVITY
#57NANOBRIDGE BIOSENSOR AND MEMORY ARRAY
#58INCREASED FUNGAL RESISTANCE IN PLANTS VIA MODULATION OF A WALL-ASSOCIATED KINASE OR BENZOXAZINOIDS
#59PHOSPHORYLATED AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#60METHODS FOR PREDICTING KINASE INHIBITOR RESISTANCE
#61METHOD FOR OVERCOMING GENETIC RESISTANCE, ENHANCING THERAPEUTIC EFFICACY, AND MINIMIZING SAFETY RISKS ASSOCIATED WITH KINASE INHIBITOR THERAPY
#62METHOD FOR CONTROLLING SPEED OF POLYPEPTIDE PASSING THROUGH NANOPORE AND USE THEREOF
#63ANALYSIS OF PROTEIN KINASES IN LIVE CELLS
#64METHODS AND COMPOSITIONS FOR THE POSITIVE SELECTION OF PROTEIN DESTABILIZERS
#65SUGAR CHAIN-RELATED GENE AND USE THEREOF
#66SYSTEMS AND METHODS FOR SINGLE-STRAND BREAK SIGNALING AND REPAIR IN A CELL-FREE SYSTEM AND METHODS OF IDENTIFYING MODULATORS OF SINGLE-STRAND BREAK SIGNALING AND REPAIR
#67BIOMARKERS OF THERAPEUTIC RESPONSIVENESS
#68KINASE ACTIVITY SIGNATURES FOR PREDICTING THE RESPONSE OF NON-SMALL-CELL LUNG CARCINOMA PATIENTS TO A PD-1 OR PD-L1 IMMUNE CHECKPOINT INHIBITOR
#69URINALYSIS TEST STRIP FOR OVER-THE-COUNTER USE
#70ON-CHIP OPTICAL REAL-TIME DNA SEQUENCING
#71ANTAGONISTS OF CAMKII-DELTA 9 AND USES THEREOF
#72Method of Treating Colorectal Cancers Using a PKC Inhibitor
#73KINASE SCREENING ASSAYS
#74BIOMARKERS OF THERAPEUTIC RESPONSIVENESS
#75[18F]-Labeled Benzothiazole Derivative As PET Radiotracer
#76METHODS TO IDENTIFY AND TREAT SUBJECTS HAVING CORTICOSTEROID-RESISTANT INFLAMMATORY DISEASES
#77ENZYMATIC CIRCUITS FOR MOLECULAR SENSORS
#78RSK INHIBITORS IN THE TREATMENT OF VIRUS DISEASES
#79SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION
#80METHOD FOR TREATING AND/OR PREVENTING REGNASE-1-RELATED DISEASE
#81AFFINITY LABELING OF DNA-LINKED LIGANDS FOR HIGH THROUGHPUT LIGAND BINDING ASSAYS AND THE USES THEREOF
#82TREATMENT OF PARKINSON'S DISEASE AND OTHER CONDITIONS CAUSED OR MEDIATED BY SENESCENT ASTROCYTES USING SMALL MOLECULE SENOLYTIC AGENTS
#83IDENTIFICATION OF MOLECULAR PATHWAYS AND METHODS OF USE THEREOF FOR TREATING RETINAL NEURODEGENERATION AND OTHER NEURODEGENERATIVE DISORDERS
#84Cell-based assay for determining activity in the retinoblastoma pathway
#85Cell-based assay for determining activity in the retinoblastoma pathway
#86Assays for detecting modified compounds
#87Treatment of Hearing Loss by Inhibition of Casein Kinase 1
#88Method for testing and screening p38 MAP kinase modifiers
#89ENZYMATIC CIRCUITS FOR MOLECULAR SENSORS
#90MEANS AND METHODS FOR DETERMINING METABOLIC ADAPTATION
#91Method for diagnosis and subtyping of adult onset Still's disease
#92ENHANCEMENT OF KINASE TARGET ENGAGEMENT
#93MEDICAMENT FOR IMPROVING OR PREVENTING SYMPTOMS RELATING TO RETINA AND/OR LIGHT RECEPTION AND METHOD FOR SCREENING FOR SUBSTANCE CAPABLE OF IMPROVING OR PREVENTING SYMPTOMS RELATING TO RETINA AND/OR LIGHT RECEPTION
#94CELLULAR ASSAYS WITH A MOLECULAR ENDPOINT MEASURED BY SAMDI MASS SPECTROMETRY
#95In vitro Transcription-Translation Metabolic Networks to Measure Quantity or Activity of Enzymes
#96METHODS FOR THE TREATMENT OF MITOCHONDRIAL GENETIC DISEASES
#97Use of UAP inhibitors to inhibit flux through the hexosamine biosynthetic pathway
#98Method for monitoring kinase activity in a sample
#99C-met modulators and methods of use
#100PLK1 TARGET PHOSPHORYLATION STATUS AND TREATMENT OF CANCER WITH PLK1 INHIBITORS
#101Enzymes and reagents for measurement of short chain fatty acids
#102Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators
#103Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators
#104Modified type A DNA polymerases
#105METHODS AND APPARATUS FOR CONDUCTING MULTIPLE MEASUREMENTS ON A SAMPLE
#106Treating liver disease by selectively eliminating senescent cells
#107Treating cardiovascular disease by selectively eliminating senescent cells
#108ON DEMAND, PORTABLE, CELL-FREE MOLECULAR SENSING PLATFORM
#109Rapid approach for detection of bacterial spores
#110METHOD FOR ASSESSING SUSCEPTIBILITY OF A VIRUS TO TREATMENT BY MEASURING ENZYME ACTIVITY AND A SYSTEM THEREFORE
#111TARGET FOR DRUG TREATMENT OF TUMOR METASTASIS AND USE THEREOF
#112NOVEL KINASE FOR TREATING AND PREVENTING FUNGAL INFECTIONS, AND USE THEREOF
#113KITS SUITABLE FOR USE IN ELECTROCHEMILUMINESCENCE METHODS AND METHODS OF EFFECTING A SPECIFIC-BINDING NON-WASH ASSAY
#114Electrochemical strips for monitoring the degradation of body fat and method for preparing same
#115WORKFLOW FOR GENERATING COMPOUNDS WITH BIOLOGICAL ACTIVITY AGAINST A SPECIFIC BIOLOGICAL TARGET
#116Methods for single molecule sequencing
#117TREATING COGNITIVE DECLINE AND OTHER NEURODEGENERATIVE CONDITIONS BY SELECTIVELY REMOVING SENESCENT CELLS FROM NEUROLOGICAL TISSUE
#118Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
#119Amino acid-sensing diguanylate cyclase and methods of use
#120Compositions and methods involving engineered p27
#121METHODS AND COMPOSITIONS FOR DIAGNOSING, TREATING, AND MONITORING TREATMENT OF SHANK3 DEFICIENCY ASSOCIATED DISORDERS
#122METHOD, APPARATUS AND SYSTEM FOR SINGLE-MOLECULE POLYMERASE BIOSENSOR WITH TRANSITION METAL NANOBRIDGE
#123Biosensors for detecting and/or neutralizing bioavailable uranium and related u-sensitive genetic molecular components, gene cassettes, vectors, genetic circuits, compositions, methods and systems
#124Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinase
#125C-Met Modulators and Methods of Use
#126BIOMARKER ASSAY FOR USE IN MONITORING AUTISM
#127COMPOSITIONS AND METHODS FOR TREATING ACUTE MYELOID LEUKEMIA
#128Method for determining sensitivity of cyclin-dependent kinase 4/6 inhibitor
#129Self-immolative probes for enzyme activity detection
#130Enzymatic circuits for molecular sensors
#131METHODS OF IDENTIFYING INDIVIDUALS AT INCREASED RISK OF LUNG CANCER
#132Method for predicting the response of non-small-cell lung carcinoma patients to a medicament
#133NEUKINASE, A DOWNSTREAM PROTEIN OF NEUREGULIN
#134Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent
#135Assays to detect neurodegeneration
#136SCREENING SYSTEM AND METHODS FOR IDENTIFYING ENZYME SUBSTRATES AND MODULATORS OF ENZYME ACTIVITY
#137Method and apparatus for measuring protein post-translational modification
#138Enzymatic circuits for molecular sensors
#139EML4-ALK translocations in lung cancer
#140Kinase mutants and uses thereof
#141CHEMICAL INHIBITORS AGAINST KINASES TO BLOCK TELOMERE ELONGATION IN CANCER
#142FLUOROPHORE-BASED KINASE SENSORS
#143Prevention and/or treatment of inflammatory skin disease
#144Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators
#145Treating cognitive decline and other neurodegenerative conditions by selectively removing senescent cells from neurological tissue
#146BIOLOGICAL SAMPLE AND BIOLOGICAL INSTRUMENT CLEANLINESS MEASUREMENT KIT AND METHOD
#147PHOSPHORYLATION OF HISTONES AND USES THEREOF
#148STAT5a AND ITS FUNCTIONAL TUMOR SUPPRESSOR ANALOGS FOR TREATMENT OF MALIGNANCIES EXPRESSING NPM/ALK AND OTHER ONCOGENIC KINASES
#149Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-YL)-pyrazolo[1,5-A]pyrimidin-3-YL)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate
#150NTRK2 FUSIONS
#151Compositions and Methods for the Assessment of Drug Target Occupancy for Bruton's Tyrosine Kinase
#152COMPOSITION FOR DIAGNOSING CANCER USING PKA ACTIVITY AND INFORMATION PROVIDING METHOD FOR DIAGNOSING METASTASIS
#153Protein kinase allostery sensor and methods of making and using same
#154ANTI-CANCER COMPOUNDS AND USES THEREOF
#155THERAPY FOR REMOVING SENESCENT CELLS AND TREATING SENESCENCE-ASSOCIATED DISEASE USING AN MDM2 INHIBITOR
#156SUGAR CHAIN-RELATED GENE AND USE THEREOF
#157Compositions and methods for altering second messenger signaling
#158NOVEL ULK1 INHIBITORS AND METHODS USING SAME
#159Kinase and/or phosphatase sensing via hydroxyquinoline-sensitized chelates
#160Assays to detect neurodegeneration
#161TREATMENT OF PARKINSON'S DISEASE AND OTHER CONDITIONS CAUSED OR MEDIATED BY SENESCENT ASTROCYTES USING SMALL MOLECULE SENOLYTIC AGENTS
#162Biomarkers of therapeutic responsiveness
#163METHODS AND APPARATUS FOR CONDUCTING MULTIPLE MEASUREMENTS ON A SAMPLE
#164ULK1 inhibitors and methods using same
#165Treatment of hearing loss by inhibition of casein kinase 1
#166Methods and compositions for the positive selection of protein destabilizers
#167DIAGNOSTIC AND THERAPEUTIC USES OF EXOSOMES
#168IN SITU VISUALIZATION OF KINASE ACTIVITY
#169Methods of detecting DDR2 mutations
#170Cytoplasmic protein complex comprising a kinase substrate sensor, cells comprising the complex, and associated detection methods
#171AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#172GSK3B and uses thereof in the diagnostic and treatment of hypopigmentation disorders
#173Inhibition of JAK-STAT signaling inhibits formation of neutrophil extracellular traps (NETs)
#174Assays for detecting modified compounds
#175Methods for predicting kinase inhibitor resistance
#176ULK1 inhibitors and methods using same
#177REGULATORS OF ANAPLASTIC LYMPHOMA KINASE AND USES THEREOF
#178MUTATIONS IN THE BCR-ABL TYROSINE KINASE ASSOCIATED WITH RESISTANCE TO STI-571
#179Cell-based assay for determining activity in the retinoblastoma pathway
#180Identifying ligands for bacterial sensors
#181Self-immolative probes for enzyme activity detection
#182Imidazopyridines Syk inhibitors
#183METHOD FOR PREDICTING THE RESPONSE OF MELANOMA PATIENTS TO A MEDICAMENT
#184Modified type A DNA polymerases
#185Method for testing and screening p38 map kinase modifiers
#186Compositions and methods for treating estrogen-related medical disorders
#187Glutamine synthetase reaction and method for quantifying ammonia utilizing the same
#188METHODS OF DIAGNOSING AND TREATING B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
#189Assay for compounds having activity against influenza
#190Compositions and methods for inhibiting kinase activity
#191Methods to identify and treat subjects having corticosteroid-resistant inflammatory diseases
#192Use of phospho-Akt as a biomarker of drug response
#193METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND FOR THE TREATMENT OF ADRENOLEUKODYSTROPHY
#194THIOSULFATE BIOSENSOR FOR GUT INFLAMMATION
#195ANTI-INFLUENZA VIRUS AGENT AND SCREENING METHOD FOR ANTI-INFLUENZA VIRUS AGENT
#196Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators
#197Systems and methods for determining cyclic nucleotide concentration and related pathway activation
#198Cyclin-dependent kinase substrate
#199Compositions and methods for modulating kinase activity
#200Nanoparticles, process for preparation and use thereof as carrier for amphipatic and hydrophobic molecules in fields of medicine including cancer treatment and food related compounds
#201EML4-ALK translocations in lung cancer
#202Enzymatic circuits for molecular sensors
#203Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss
#204MODIFIED BACTERIAL NANOCELLULOSE AND ITS USES IN CHIP CARDS AND MEDICINE
#205METHODS AND COMPOSITIONS FOR DIAGNOSING, TREATING, AND MONITORING TREATMENT OF SHANK3 DEFICIENCY ASSOCIATED DISORDERS
#206Method for predicting the response of melanoma patients to targeted pharmacotherapy
#207LYMPHOCYTE-BASED PKCe TEST FOR ALZHEIMER'S DISEASE
#208Kinase substrates and methods of use thereof
#209Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders using an inhibitor of Akt kinase
#210Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
#211Removing senescent cells from a mixed cell population or tissue using a phosphoinositide 3-kinase (PI3K) inhibitor
#212Kits suitable for use in electrochemiluminescence methods and methods of effecting a specific-binding non-wash assay
#213Method and apparatus for measuring protein post-translational modification
#214EGFR MUTATIONS
#215Compositions of matter for treatment of ophthalmic conditions by selectively removing senescent cells from the eye
#216Cellular assays with a molecular endpoint measured by SAMDI mass spectrometry
#217MEl'hods and means for diagnosing spondylarthritis using autoantibody markers
#218Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate
#219RUBBER-LIKE MATERIAL FOR THE IMMOBILIZATION OF PROTEINS AND ITS USE IN LIGHTING, DIAGNOSIS AND BIOCATALYSIS
#220Compositions and methods for controlling vasculature
#221Method for screening pharmaceuticals for treatment of steatohepatitis using N-terminal dimerization of apoptosis signal-regulated kinase1
#222Use of UAP inhibitors to inhibit flux through the hexosamine biosynthetic pathway
#223Protein standard compositions and methods of making and using the same
#224Compositions and methods for altering second messenger signaling
#225Compounds
#226Methods, compositions and kits for high throughput kinase activity screening using mass spectrometry and stable isotopes
#227Compositions and methods for altering second messenger signaling
#228Quantification method for ammonia, quantification reagent kit, test piece, and ammonia quantification device
#229NEURAL STEM CELL THERAPY FOR OBESITY AND DIABETES
#230METHOD FOR EXTRACTING LEAD COMPOUND, METHOD FOR SELECTING DRUG DISCOVERY TARGET, DEVICE FOR CREATING SCATTER DIAGRAM, AND DATA VISUALIZATION METHOD AND VISUALIZATION DEVICE
#231IMIDAZOPYRAZINE SYK INHIBITORS
#232EML4-ALK FUSION GENE
#233Methods And Compositions For Detection Of Cowden Syndrome (CS) And CS-Like Syndrome
#234DETECTION OF NUCLEIC ACID POLYMERASE CONFORMATIONAL CHANGES USING A NANOTUBE
#235BIOMARKER FOR PARKINSON'S DISEASE AND USE THEREOF
#236Protein kinase C inhibitors and uses thereof
#237Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate
#238Method of treating colorectal cancers using a PKC inhibitor
#239Compositions and methods for treating multiple myeloma
#240BIOPHYSICAL PLATFORM FOR DRUG DEVELOPMENT BASED ON ENERGY LANDSCAPE
#241C-met modulators and methods of use
#242Phosphatase or kinase activity detection composition and detection method
#243Tyrosine kinase biosensors and methods of use
#244ULK1 inhibitors and methods using same
#245METHOD TO PREDICT THE LACK OF RESPONSE TO ANTI-TNF ALPHA THERAPIES
#246P21-activated kinase inhibitor domain targeted transgenic mouse
#247HBV RNAse H purification and enzyme inhibitors
#248Substrates for FLT3 kinase and uses thereof
#249N-substituted 4-aminoquinazoline derivatives and methods of use
#250Enhancement of tumor response to chemotherapy by activation of the ASMase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent
#251Digital polymerase fidelity assay
#252Neukinase, a downstream protein of neuregulin
#253Measuring method and composition using kinase
#254Method for the Identification of Inhibitors and Activators of Thymidylate Kinases
#255PHOSPHORYLATION OF HISTONES AND USES THEREOF
#256ANTI-INFLUENZA VIRUS AGENT AND SCREENING METHOD FOR ANTI-INFLUENZA VIRUS AGENT
#257ALK AND ROS KINASE IN CANCER
#258Methods of detecting DDR2 mutations
#259Nanoparticles, process for preparation and use thereof as carrier for amphipatic and hydrophobic molecules in fields of medicine including cancer treatment and food related compounds
#260Method for evaluating mesenchymal stem cell activity, method for culturing mesenchymal stem cells, method for producing therapeutic agent for liver dysfunction, and therapeutic agent for liver dysfunction
#261Methods for generating engineered enzymes
#262Ligand-directed covalent modification of protein
#263Biomarkers of therapeutic responsiveness
#264Fluorescent AMP-kinase biosensors
#265Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
#266Tyrosine kinase biosensors and methods of use
#267Method for measuring protein kinase activity and kit for same
#268Cardiotonic steroid antagonists and related methods
#269Diagnosis methods, diagnostic agents, and therapeutic agents against alzheimer's disease and frontotemporal lobar degeneration, and screening methods for these agents
#270COMPOSITION FOR DIAGNOSING CANCER USING PKA ACTIVITY AND INFORMATION PROVIDING METHOD FOR DIAGNOSING METASTASIS
#271Method of Modulating Protein 14-3-3 Functionality By Facilitating or Inhibiting Phosphorylation
#272Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate
#273METHODS AND PRODUCTS RELATING TO GSK3ß REGULATION
#274METHODS OF IDENTIFYING ENZYMES AND MICROORGANISMS
#275Predicting response to cancer therapy
#276Method for detection of a TECR:PKN1 or an ANXA4:PKN1 gene fusion
#277Method and kit for quantifying cardiolipin
#278Compositions and methods for treating estrogen-related medical disorders
#279STAT5a and its functional tumor suppressor analogs for treatment of malignancies expressing NPM/ALK and other oncogenic kinases
#280Degradation resistant peptide based biosensors
#281REGULATORS OF ANAPLASTIC LYMPHOMA KINASE AND USES THEREOF
#282Immobilized protein system for rapid and enhanced multiplexed diagnostics
#283Multiplexed Proteomics and Phosphoproteomics
#284Methods and compositions for treating infection
#285Covalently linked thermostable kinase for decontamination process validation
#286MODIFIED TYPE A DNA POLYMERASES
#287Kit and method for measuring the activity of deoxynucleoside kinase
#288CaMKK-β as a target for treating cancer
#289Biomarker for parkinson's disease and use thereof
#290Kinase activity detection methods
#291CONTEMPORANEOUS, HETEROGENEOUSLY-ORIENTED, MULTI-TARGETED THERAPEUTIC MODIFICATION AND/OR MODULATION OF DISEASE BY ADMINISTRATION OF SULFUR-CONTAINING, AMINO ACID-SPECIFIC SMALL MOLECULES
#292Bcl-2-like protein 11 SRM/MRM assay
#293KINASE ACTIVITY DETECTION METHODS
#294Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases
#295LKB1 related diagnostics and treatments of cancer
#296Fusion gene as therapeutic target in proliferative diseases
#297Method of preventing or treating skin necroptosis disease comprising RIP3-MLKL pathway blocker
#298METHOD OF IDENTIFYING A CELL WITH AN INTRACELLULAR CONCENTRATION OF A SPECIFIC METABOLITE, WHICH INTRACELLULAR CONCENTRATION IS INCREASED IN COMPARISON WITH THE CELL'S WILDTYPE, WHERE THE MODIFICATION OF THE CELL IS ACHIEVED BY RECOMBINEERING
#299METHODS FOR PROGNOSING THE ABILITY OF A ZEARALENONE ANALOG COMPOUND TO TREAT CANCER
#300Biomarker for MELK activity and methods of using same